Futura Medical Plc (FAMDF) 0.2800 $FAMDF Cellulite

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Futura Medical Plc (FAMDF) 0.2800 $FAMDF

Cellulite Global Clinical Trials Review 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Endo International, Futura Medical, Nestle - Research and Markets
BusinessWire - Wed May 04, 4:03AM CDT
Research and Markets has announced the addition of the "Cellulite Global Clinical Trials Review, H1, 2016" clinical trials to their offering.

Cellulite Global Clinical Trials Review, H1, 2015
M2 - Thu Sep 24, 9:59AM CDT
Research and Markets (http://www.researchandmarkets.com/research/65jxhb/cellulite_global) has announced the addition of the "Cellulite Global Clinical Trials Review, H1, 2015" report to their offering. This report provides an overview of Cellulite clinical trials scenario. This report provides top line data relating to the clinical trials on Cellulite. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical trials are collated from 80 different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. Reasons to Buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level Companies Mentioned - ALIO MEDICA - Endo International - Futura Medical - Halozyme Therapeutics - L. Manetti H. Roberts & C. - Nutrasource Diagnostics - Premier Research - Royal DSM - Venus Remedies For more information visit http://www.researchandmarkets.com/research/65...ite_global

Global Erectile Dysfunction Pipeline Review 2015
M2 - Tue Sep 08, 5:26AM CDT
Research and Markets (http://www.researchandmarkets.com/research/bhsbsn/erectile) has announced the addition of the "Erectile Dysfunction - Pipeline Review, H2 2015" report to their offering. This report provides comprehensive information on the therapeutic development for Erectile Dysfunction, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Erectile Dysfunction and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Companies Involved in Therapeutics Development - Acorda Therapeutics, Inc. - Apricus Biosciences, Inc. - Aprogen, Inc. - Bioheart, Inc. - Biolab Sanus Farmaceutica Ltda. - Corridor Pharmaceuticals Inc. - Futura Medical Plc - Hanmi Pharmaceuticals, Co. Ltd. - IntelGenx Corp. - Mezzion Pharma Co. Ltd. - Mitsubishi Tanabe Pharma Corporation - Monosol Rx, LLC - NAL Pharmaceuticals Ltd. - Pacific Therapeutics Ltd. - Palatin Technologies, Inc. - Pharmicell Co., Ltd. - Sagene Pharmaceuticals, Inc. - Suda Ltd - Yungjin Pharm Ind. Co., Ltd. For more information visit http://www.researchandmarkets.com/research/bhsbsn/erectile
PTN: 0.80 (+0.10), APRI: 0.32 (unch), ACOR: 24.95 (-1.76)

New Generation Topical Pain Relief From Futura Medical
PR Newswire Europe - Wed Jul 15, 4:01AM CDT
LONDON, July 15, 2015 /PRNewswire/ --

Erectile Dysfunction Therapeutic Pipeline Review H2 2015 Market Research Report at RnRMarketResearch.com
PRWeb - Sun Jan 25, 1:30PM CST
The report "Erectile Dysfunction - Pipeline Review, H1 2015" provides comprehensive information on the therapeutic development for Erectile Dysfunction. Erectile dysfunction is the failure to get or keep an erection firm enough to have sexual intercourse. However, frequent Erectile dysfunction can be a sign of health problems that need treatment. Erectile dysfunction can have severe mental consequences as it can be joined to relationship difficulties and masculine self-image generally. Research indicates that approximately 40% of males suffer from erectile dysfunction. Complete report is available at http://www.rnrmarketresearch.com/erectile-dys...eport.html .
PTN: 0.80 (+0.10), APRI: 0.32 (unch)

Global Premature Ejaculation Market 2014-2018: Key Vendors are Absorption, Furiex, Innovus and Plethora
M2 - Thu Oct 09, 4:13AM CDT
Research and Markets (http://www.researchandmarkets.com/research/thdrgd/global_premature) has announced the addition of the "Global Premature Ejaculation Market 2014-2018" report to their offering. Premature ejaculation is a common sexual dysfunction in men, which is characterized by early discharge of semen. Premature ejaculation can be diagnosed through IELT, which is the average time taken by a man to ejaculate during sexual intercourse. There are two types of premature ejaculation: Primary premature ejaculation and secondary premature ejaculation. The analysts forecast the Global Premature Ejaculation market to grow at a CAGR of 10.20 percent over the period 2013-2018. This report covers the present scenario and the growth prospects of the Global Premature Ejaculation market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of premature ejaculation that are available in the market. The report also presents the vendor landscape and a corresponding detailed analysis of the top four vendors in the Global Premature Ejaculation market. In addition, the report discusses the major drivers that influence the growth of the market and outlines the challenges faced by the vendors and the market at large. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Product Profiles 05. Market Research Methodology 06. Introduction 07. Disease Overview and Management 08. Market Landscape 09. Market Segmentation by Route of Administration 10. Market Segmentation by Dosage Form 11. Market Segmentation by Mechanism of Action 12. Geographical Segmentation 13. Buying Criteria 14. Market Growth Drivers 15. Drivers and their Impact 16. Market Challenges 17. Impact of Drivers and Challenges 18. Market Trends 19. Trends and their Impact 20. Vendor Landscape 21. Pipeline Portfolio 22. Key Vendor Analysis 23. Other Reports in this Series Companies Mentioned: - Absorption - Furiex - Innovus - Plethora - Bayer - Dong-A ST - Eli Lilly - Emcure - Endo - Futura Medical - GlaxoSmithKline - Medisyn - Menarini - NeuroHealing - Pfizer - Shionogi - Symyoo - Vectura - Vyrix For more information visit http://www.researchandmarkets.com/research/th..._premature
LLY: 82.93 (-0.47), GSK: 45.18 (+0.06)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 334

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 423

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 256

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 301

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Newegg’s GIGABYTE Event Is Brand Work, Not a Catalyst

Updated Category News Views 448

A 2,300-square-foot room can tell a retailer plenty about its tribe. On November 21, Newegg is turning its Diamond Bar Gamer Zone into the home base for GIGABYTE’s AORUS VS40 celebration, a free five-hour event marking the hardware maker’s 40th anniversary. There will be 1v1 VALORANT and League of Legends contests, demo stations, raffles, anniversary merchandise, food...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 215

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Employer Ghosting Is a Quiet Talent-Cost Problem Today

Updated Category News Views 349

Silence is cheap right up until a company needs talent again. Then the unanswered email, abandoned interview loop, or vanished promise of next steps comes back with a price tag—maybe not neatly labeled in a quarterly filing, but real all the same. LiveCareer’s April 14, 2026 survey of 1,008 employed U.S. adults lands on an uncomfortable point: candidates remember...

Continue Reading
Persistent Dry Eye Symptoms Call for a Closer Look

Updated Category News Views 245

Eyes can turn into a stubborn little nuisance long before people realize something more complicated is going on. A bottle of artificial tears is easy to grab, cheap enough, and often perfectly sensible for a rough day of screens, wind, reading, or air conditioning. But Dr. Harlan Snyder’s point is the one worth sitting with: when dryness keeps barging back despite...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 285

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 412

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading

Top 5 Most Recently Viewed Articles

TransAlta Announces Right to Convert Series G Preferred Shares

Updated Category News Views 124

Update on TransAlta's Series G Preferred Shares TransAlta Corporation (TSX: TA; NYSE: TAC) has shared important news about its cumulative redeemable rate reset first preferred shares, known as Series G. The company has decided not to exercise its right to redeem these shares on the upcoming conversion date. Details on the Conversion of Series G Shares Holders of Series G...

Continue Reading
Automotive Engine Oil Market Surge: Innovations and Challenges

Updated Category News Views 469

The Rising Tide of the Automotive Engine Oil Market The global automotive engine oil market is on a exciting trajectory, projected to grow significantly in the coming years. This growth can largely be attributed to the increasing number of vehicles on the roads and advancements in engine oil technology. Experts estimate that the market will grow by approximately USD 12.5...

Continue Reading
Understanding Ferguson Enterprises' Price-to-Earnings Ratio

Updated Category News Views 112

Ferguson Enterprises Inc. Recent Stock Performance As we delve into Ferguson Enterprises Inc. (NYSE: FERG), the current trading price stands at $227.06, reflecting a slight decrease of 0.71%. In the preceding month, the stock has experienced a drop of 10.00%. However, when we take a year-long view, it’s noteworthy that the stock has actually appreciated by 30.82%. This...

Continue Reading
Cyabra to Engage in Needham Growth Conference: What to Expect

Updated Category News Views 100

Cyabra to Engage in Needham Growth Conference Cyabra Ltd., a pioneering AI platform focused on the detection of real-time disinformation, is set to participate in an influential industry event: the 27th Annual Needham Growth Conference. This virtual conference presents an exciting opportunity for investors and stakeholders to connect with Cyabra's leadership, specifically...

Continue Reading
Job Market Frustrations: The Truth Behind 'Remote Work' Claims

Updated Category News Views 451

Job Seekers Faces Misleading Remote Work Claims Recently, stories shared online illustrate a frustrating trend in the job market, particularly concerning remote work commitments. Job seekers are collectively expressing outrage over interviews that promise flexible arrangements only to reveal hidden requirements for in-office presence. This alarming shift has spurr

Continue Reading